BC Craft Supply Co. Ltd. (CRFTF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBC Craft Supply Co. Ltd. (CRFTF) trades at $0.00001. BC Craft Supply Co. Ltd. is a Canadian life sciences firm focused on cannabinoid and psychedelic research for therapeutic applications. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for CRFTF: CRFTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
BC Craft Supply Co. Ltd. (CRFTF) Healthcare & Pipeline Overview
BC Craft Supply Co. Ltd. operates as a multifaceted life sciences enterprise, pioneering advancements in cannabinoid and psychedelic research for therapeutic applications. The company strategically consolidates artisan cannabis, manages cultivation facilities, and develops pre-clinical neuroplasticity solutions, positioning itself across both the Canadian and Californian emerging markets.
What Is the Investment Thesis for CRFTF?
BC Craft Supply Co. Ltd. is positioned within the evolving cannabinoid and psychedelic research sectors, aiming to capitalize on the growing demand for both craft cannabis and novel therapeutic applications. The company's strategy involves consolidating artisan cannabis through CRFT, operating cultivation facilities via Medcann Health Products, and expanding into the California market with Feelwell Brands. A key value driver is its pre-clinical biotechnology arm, AVA Pathways, which focuses on neuroplasticity and psychedelic compounds, potentially unlocking significant long-term growth in mental health solutions. However, the company faces substantial challenges, evidenced by a profit margin of -2613.0% and a gross margin of 5.8%, indicating significant operational inefficiencies or early-stage investment. Its high Beta of 5.15 suggests considerable price volatility. As an OTC Other listed stock, CRFTF carries inherent risks related to lower liquidity and less stringent disclosure requirements. Future performance hinges on effective scaling of operations, successful navigation of complex regulatory landscapes in both cannabis and psychedelics, and maintaining access to capital to fund ongoing research and market expansion.
Based on FMP financials and quantitative analysis
CRFTF Key Highlights
The company maintains a gross margin of 5.8%, indicating the percentage of revenue remaining after accounting for the cost of goods sold.
- BC Craft Supply Co. Ltd. reported a profit margin of -2613.0%, reflecting significant losses relative to its revenue.
- With a market capitalization of $0.00 billion, the company currently holds a minimal valuation in the public markets.
- The stock exhibits a high Beta of 5.15, suggesting it is significantly more volatile than the broader market.
- BC Craft Supply Co. Ltd. does not currently pay a dividend, as indicated by a dividend yield of None.
Who Are CRFTF's Competitors?
CRFTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $20.9M | — |
| AYTU Aytu BioPharma, Inc. | $2.04 | -1.45% | $21.9M | — |
| TXMD TherapeuticsMD, Inc. | $2.01 | -1.95% | $24.0M | — |
| CPHI CPHI | $0.65 | -0.61% | $27.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CRFTF's Key Strengths?
Diversified portfolio across craft cannabis, cultivation, cannabinoid brands, and psychedelic research.
- Strategic presence in both Canadian and Californian cannabis markets.
- Focus on the growing craft cannabis segment and emerging psychedelic therapeutics.
- Established cultivation and processing facility via Medcann Health Products.
- Pioneering pre-clinical research in neuroplasticity with AVA Pathways.
What Are CRFTF's Weaknesses?
Significant negative profit margin (-2613.0%) indicating substantial losses.
- Low gross margin (5.8%) suggesting high cost of goods or pricing pressures.
- Operates as an OTC Other listed stock, implying lower liquidity and less transparency.
- High Beta (5.15) indicates extreme price volatility and market risk.
- Pre-clinical nature of AVA Pathways means long timelines and high risk for drug development.
What Are the Key Risks for CRFTF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant financial losses and negative profit margins may lead to ongoing cash burn and require further capital raises.
- High stock volatility (Beta 5.15) could result in substantial and rapid share price fluctuations.
- Regulatory changes or increased scrutiny in the cannabis and psychedelic sectors could impact operations and market opportunities.
- Intense competition from larger, better-funded companies in both the cannabis and pharmaceutical industries.
- Risks associated with an OTC Other listing, including low liquidity, limited transparency, and potential for market manipulation.
What Threats Does CRFTF Face?
- Intense competition from larger, well-funded cannabis companies and pharmaceutical firms.
- Evolving and complex regulatory landscapes in both cannabis and psychedelics.
- Challenges in scaling operations effectively and maintaining access to capital.
- Risk of research failures or lengthy approval processes for psychedelic compounds.
- Market volatility and liquidity issues associated with OTC Other listing.
What Are CRFTF's Competitive Advantages?
- Strategic positioning in the craft cannabis segment, catering to a niche market with potentially higher margins and brand loyalty.
- Diversified portfolio spanning both cannabinoid products and pre-clinical psychedelic research, mitigating reliance on a single market.
- Established cultivation and processing infrastructure in Canada through Medcann Health Products, ensuring supply chain control.
- Early-mover advantage in pre-clinical psychedelic research via AVA Pathways, exploring novel mental health treatments.
- Licensing and operational presence in the significant California cannabis market through Feelwell Brands.
What Does CRFTF Do?
BC Craft Supply Co. Ltd. is a multifaceted life sciences enterprise headquartered in Vancouver, Canada, dedicated to pioneering advancements in cannabinoid and psychedelic research, specifically targeting innovative therapeutic and psychotherapeutic applications. The company, which was formerly known as Pasha Brands Ltd. before adopting its current name in May 2020, has strategically diversified its operations across several key ventures within these burgeoning sectors. At its core, CRFT functions as a discerning curator and consolidator of artisan cannabis, playing a crucial role in championing small-batch cultivators and facilitating their access and entry into the competitive Canadian market. This segment focuses on quality and authenticity, aiming to meet the demand for premium cannabis products. Further expanding its footprint in the cannabis industry, Medcann Health Products operates a cultivation and processing facility located in Chemainus. This facility is pivotal in serving both the medical and recreational cannabis sectors across Canada, ensuring a consistent supply chain and product development capabilities. In a strategic move to penetrate the significant U.S. market, Feelwell Brands operates as a cannabinoid brand collective, holding a license specifically in California, a key state for cannabis innovation and consumption. This allows BC Craft Supply Co. Ltd. to tap into a broader consumer base and explore diverse product lines. Beyond cannabinoids, the company is actively engaged in the frontier of psychedelic research through AVA Pathways. This pre-clinical biotechnology firm is intensely focused on neuroplasticity, exploring mental health solutions through the study of psilocybin and other mushroom-derived compounds. This venture represents a forward-looking commitment to developing novel treatments for mental health conditions, leveraging the therapeutic potential of psychedelics. Through this diverse portfolio, BC Craft Supply Co. Ltd. aims to establish a significant presence across the life sciences landscape, from craft cannabis market consolidation to cutting-edge psychedelic drug discovery.
What Products and Services Does CRFTF Offer?
- Curates and consolidates artisan cannabis from small-batch cultivators for the Canadian market through its CRFT venture.
- Operates a cultivation and processing facility via Medcann Health Products for medical and recreational cannabis in Canada.
- Manages Feelwell Brands, a cannabinoid brand collective with a license to operate in California, USA.
- Conducts pre-clinical biotechnology research on neuroplasticity using psilocybin and other mushroom-derived compounds through AVA Pathways.
- Focuses on developing innovative therapeutic and psychotherapeutic applications for cannabinoids and psychedelics.
- Facilitates market entry for small-batch cannabis cultivators in Canada, supporting the craft segment.
- Explores mental health solutions through its psychedelic research arm.
How Does CRFTF Make Money?
- Revenue generation from the sale of curated craft cannabis products in Canada.
- Sales of medical and recreational cannabis products cultivated and processed at the Medcann Health Products facility.
- Brand development and sales of cannabinoid products in the California market through Feelwell Brands.
- Potential future revenue from intellectual property, licensing, or commercialization of psychedelic compounds developed by AVA Pathways.
- Providing infrastructure and services to craft cannabis cultivators.
What Industry Does CRFTF Operate In?
BC Craft Supply Co. Ltd. operates within the dynamic and rapidly evolving healthcare sector, specifically targeting the Drug Manufacturers - Specialty & Generic industry with a unique focus on cannabinoids and psychedelics. The global cannabis market is experiencing significant growth, driven by increasing legalization for medical and recreational use, with projections indicating continued expansion. Similarly, the psychedelic therapeutics market is an emerging frontier, attracting substantial research and investment due to the potential of compounds like psilocybin for mental health treatments. BC Craft Supply Co. Ltd. positions itself by addressing both these trends: through CRFT, it taps into the premium craft cannabis segment, differentiating from larger, mass-market producers. Its Medcann and Feelwell brands aim for broader market penetration in Canada and California, respectively. AVA Pathways places it in the nascent but high-potential psychedelic research space, competing with a growing number of biotech firms exploring neuroplasticity. The competitive landscape includes established pharmaceutical companies, large-scale cannabis cultivators, and specialized biotech startups, all vying for market share in these innovative but highly regulated fields.
Who Are CRFTF's Key Customers?
- Canadian consumers of legal medical and recreational cannabis, particularly those seeking premium, artisan products.
- Consumers in California seeking cannabinoid products under the Feelwell Brands collective.
- Medical patients in Canada requiring cannabis for therapeutic purposes.
- Small-batch cannabis cultivators seeking market access and consolidation services in Canada.
- Potentially, pharmaceutical companies or healthcare providers for future psychedelic therapeutics developed by AVA Pathways.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
BC Craft Supply Co. Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for BC Craft Supply Co. Ltd. stands at 24.9%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
BC Craft Supply Co. Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Bradley Macauley. CRFTF has traded publicly since 2019.
CRFTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
CRFTF Latest News
No recent news available for CRFTF.
CRFTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CRFTF.
Price Targets
Wall Street price target analysis for CRFTF.
CRFTF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CRFTF; grades run from A+ (80-100) to F (below 30).
CRFTF OTC Market Information
BC Craft Supply Co. Ltd. trades on the OTC Other tier, which is the lowest and least regulated tier of the OTC Markets Group. Unlike stocks listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers like OTCQB or OTCQX, companies on the OTC Other tier are not required to meet minimum financial standards or file regular reports with the SEC. This tier typically includes companies that are very small, distressed, or do not meet the requirements for higher tiers, offering significantly less transparency and investor protection compared to other public markets. Investors should be aware of the inherent risks associated with this classification.
- OTC Tier: OTC Other
- Limited public information and less stringent disclosure requirements compared to major exchanges.
- Lower trading volume and wider bid-ask spreads, leading to reduced liquidity and difficulty in executing trades.
- Increased susceptibility to price manipulation due to less oversight and smaller market capitalization.
- Limited analyst coverage and institutional interest, which can hinder accurate valuation and market efficiency.
- Potential for delisting or further regulatory actions if disclosure status remains unknown or inadequate.
- Verify the company's current operational status and revenue streams beyond public filings.
- Scrutinize available financial statements, even if unaudited, for consistency and red flags.
- Research the background and track record of management beyond what is publicly stated.
- Understand the company's share structure, including any convertible notes or warrants that could dilute existing shareholders.
- Assess the regulatory environment specific to its cannabis and psychedelic operations in Canada and California.
- Investigate any pending litigation or regulatory actions against the company or its subsidiaries.
- Evaluate the company's access to capital and its ability to fund ongoing operations and growth initiatives.
- Clearly defined business segments including CRFT, Medcann Health Products, Feelwell Brands, and AVA Pathways.
- Specific operational locations mentioned, such as Chemainus for Medcann and Vancouver for HQ.
- Named CEO, Bradley Macauley, indicating identifiable leadership.
- Engagement in regulated industries (cannabis) and emerging research (psychedelics) with specific licenses (California).
- History of name change from Pasha Brands Ltd. to BC Craft Supply Co. Ltd. in May 2020, indicating corporate evolution.
BC Craft Supply Co. Ltd. Healthcare Stock: Key Questions Answered
What does BC Craft Supply Co. Ltd. do?
BC Craft Supply Co. Ltd. operates as a diversified life sciences company with a strategic focus on both the cannabinoid and psychedelic sectors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- OTC Disclosure Status is 'Unknown' as per source data.